Twist Bioscience Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	376.57	312.97	245.11	203.57	132.33
Revenue Growth (YoY)	20.32%	27.69%	20.41%	53.83%	46.87%
Cost of Revenue	185.57	179.63	155.38	119.33	80.62
Gross Profit	191	133.35	89.73	84.24	51.71
Selling, General & Admin	246.98	218.4	189.74	212.95	135.9
Research & Development	80.29	90.85	106.89	120.31	69.07
Operating Expenses	327.26	309.25	296.63	333.26	204.97
Operating Income	-136.26	-175.9	-206.9	-249.02	-153.26
Interest Expense	-	-	-	-0.08	-0.37
Interest & Investment Income	11.36	15.34	14.37	3.06	0.44
Other Non Operating Income (Expenses)	-0.9	-2.68	-0.67	-1.09	-
EBT Excluding Unusual Items	-125.8	-163.24	-193.21	-247.13	-153.19
Merger & Restructuring Charges	-	-	-9.38	-	-
Gain (Loss) on Sale of Assets	48.85	-	-	4.61	-
Asset Writedown	-	-44.93	-6.79	-	-
Other Unusual Items	-	-	5.91	14.25	-0.84
Pretax Income	-76.95	-208.17	-203.47	-228.27	-154.03
Income Tax Expense	0.72	0.56	1.15	-10.41	-1.93
Net Income	-77.67	-208.73	-204.62	-217.86	-152.1
Net Income to Common	-77.67	-208.73	-204.62	-217.86	-152.1
Shares Outstanding (Basic)	60	58	57	54	48
Shares Outstanding (Diluted)	60	58	57	54	48
Shares Change (YoY)	3.09%	1.99%	5.57%	11.68%	23.12%
EPS (Basic)	-1.30	-3.60	-3.60	-4.04	-3.15
EPS (Diluted)	-1.30	-3.60	-3.60	-4.04	-3.15
Free Cash Flow	-75.63	-69.17	-170.25	-226.24	-139.31
Free Cash Flow Per Share	-1.26	-1.19	-2.99	-4.20	-2.89
Gross Margin	50.72%	42.61%	36.61%	41.38%	39.08%
Operating Margin	-36.18%	-56.20%	-84.41%	-122.33%	-115.81%
Profit Margin	-20.63%	-66.69%	-83.48%	-107.02%	-114.94%
Free Cash Flow Margin	-20.08%	-22.10%	-69.46%	-111.14%	-105.27%
EBITDA	-114.31	-147.07	-177.59	-232.51	-143.51
EBITDA Margin	-30.35%	-46.99%	-72.45%	-114.22%	-108.45%
D&A For EBITDA	21.95	28.83	29.31	16.51	9.75
EBIT	-136.26	-175.9	-206.9	-249.02	-153.26
EBIT Margin	-36.18%	-56.20%	-84.41%	-122.33%	-115.81%
Advertising Expenses	7	5.2	2.9	2.4	2.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.